Literature DB >> 30389227

Recent advances in antenatal factors predisposing to bronchopulmonary dysplasia.

Elizabeth Taglauer1, Steven H Abman2, Roberta L Keller3.   

Abstract

Bronchopulmonary dysplasia (BPD) remains a major cause of late morbidities and death after preterm birth. BPD is characterized by an arrest of vascular and alveolar growth and high risk for pulmonary hypertension; yet mechanisms contributing to its pathogenesis and early strategies to prevent BPD are poorly understood. Strong epidemiologic studies have shown that the "new BPD" reflects the long-lasting impact of antenatal factors on lung development, partly due to placental dysfunction, as reflected in recent data from animal models. Improved understanding of mechanisms through which antenatal stress alters placental function and contributes to BPD may lead to preventive therapies.
Copyright © 2018. Published by Elsevier Inc.

Entities:  

Keywords:  Alveolarization; Angiogenesis; Placenta; Respiratory morbidity; Vascular endothelial growth factor (VEGF); Vasculogenesis

Mesh:

Substances:

Year:  2018        PMID: 30389227      PMCID: PMC6286866          DOI: 10.1053/j.semperi.2018.09.002

Source DB:  PubMed          Journal:  Semin Perinatol        ISSN: 0146-0005            Impact factor:   3.300


  75 in total

1.  Pulmonary disease following respirator therapy of hyaline-membrane disease. Bronchopulmonary dysplasia.

Authors:  W H Northway; R C Rosan; D Y Porter
Journal:  N Engl J Med       Date:  1967-02-16       Impact factor: 91.245

2.  Inhibition of angiogenesis decreases alveolarization in the developing rat lung.

Authors:  M Jakkula; T D Le Cras; S Gebb; K P Hirth; R M Tuder; N F Voelkel; S H Abman
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2000-09       Impact factor: 5.464

3.  Early pulmonary vascular disease in preterm infants at risk for bronchopulmonary dysplasia.

Authors:  Peter M Mourani; Marci K Sontag; Adel Younoszai; Joshua I Miller; John P Kinsella; Christopher D Baker; Brenda B Poindexter; David A Ingram; Steven H Abman
Journal:  Am J Respir Crit Care Med       Date:  2015-01-01       Impact factor: 21.405

4.  Blood protein concentrations in the first two postnatal weeks that predict bronchopulmonary dysplasia among infants born before the 28th week of gestation.

Authors:  Carl Bose; Matthew Laughon; Elizabeth N Allred; Linda J Van Marter; T Michael O'Shea; Richard A Ehrenkranz; Raina Fichorova; Alan Leviton
Journal:  Pediatr Res       Date:  2011-04       Impact factor: 3.756

5.  Prediction of bronchopulmonary dysplasia by postnatal age in extremely premature infants.

Authors:  Matthew M Laughon; John C Langer; Carl L Bose; P Brian Smith; Namasivayam Ambalavanan; Kathleen A Kennedy; Barbara J Stoll; Susie Buchter; Abbot R Laptook; Richard A Ehrenkranz; C Michael Cotten; Deanne E Wilson-Costello; Seetha Shankaran; Krisa P Van Meurs; Alexis S Davis; Marie G Gantz; Neil N Finer; Bradley A Yoder; Roger G Faix; Waldemar A Carlo; Kurt R Schibler; Nancy S Newman; Wade Rich; Abhik Das; Rosemary D Higgins; Michele C Walsh
Journal:  Am J Respir Crit Care Med       Date:  2011-03-04       Impact factor: 21.405

6.  Prenatal and Perinatal Determinants of Lung Health and Disease in Early Life: A National Heart, Lung, and Blood Institute Workshop Report.

Authors:  Tracy A Manuck; Philip T Levy; Cynthia Gyamfi-Bannerman; Alan H Jobe; Carol J Blaisdell
Journal:  JAMA Pediatr       Date:  2016-05-02       Impact factor: 16.193

7.  Resident Endothelial Progenitor Cells From Human Placenta Have Greater Vasculogenic Potential Than Circulating Endothelial Progenitor Cells From Umbilical Cord Blood.

Authors:  Brian M Rapp; M Reza Saadatzedeh; Richard H Ofstein; Janak R Bhavsar; Zachary S Tempel; Oscar Moreno; Peter Morone; Dana A Booth; Dmitry O Traktuev; Michael C Dalsing; David A Ingram; Mervin C Yoder; Keith L March; Michael P Murphy
Journal:  Cell Med       Date:  2011-12-09

8.  Pregnancy disorders that lead to delivery before the 28th week of gestation: an epidemiologic approach to classification.

Authors:  T F McElrath; J L Hecht; O Dammann; K Boggess; A Onderdonk; G Markenson; M Harper; E Delpapa; E N Allred; A Leviton
Journal:  Am J Epidemiol       Date:  2008-08-27       Impact factor: 4.897

9.  Trends in Care Practices, Morbidity, and Mortality of Extremely Preterm Neonates, 1993-2012.

Authors:  Barbara J Stoll; Nellie I Hansen; Edward F Bell; Michele C Walsh; Waldemar A Carlo; Seetha Shankaran; Abbot R Laptook; Pablo J Sánchez; Krisa P Van Meurs; Myra Wyckoff; Abhik Das; Ellen C Hale; M Bethany Ball; Nancy S Newman; Kurt Schibler; Brenda B Poindexter; Kathleen A Kennedy; C Michael Cotten; Kristi L Watterberg; Carl T D'Angio; Sara B DeMauro; William E Truog; Uday Devaskar; Rosemary D Higgins
Journal:  JAMA       Date:  2015-09-08       Impact factor: 56.272

Review 10.  Effects of chorioamnionitis on the fetal lung.

Authors:  Alan H Jobe
Journal:  Clin Perinatol       Date:  2012-09       Impact factor: 3.430

View more
  23 in total

1.  Assessment of early nutritional intake in preterm infants with bronchopulmonary dysplasia: a cohort study.

Authors:  Brunna G Milanesi; Paola At Lima; Letícia D Villela; Amanda S Martins; Saint Clair S Gomes-Junior; Maria E L Moreira; Maria Dalva Barbosa Baker Méio
Journal:  Eur J Pediatr       Date:  2021-01-03       Impact factor: 3.183

Review 2.  Bronchopulmonary dysplasia.

Authors:  Bernard Thébaud; Kara N Goss; Matthew Laughon; Jeffrey A Whitsett; Steven H Abman; Robin H Steinhorn; Judy L Aschner; Peter G Davis; Sharon A McGrath-Morrow; Roger F Soll; Alan H Jobe
Journal:  Nat Rev Dis Primers       Date:  2019-11-14       Impact factor: 52.329

3.  Differences in clinical and laboratory biomarkers for short and long-term respiratory outcomes in preterm neonates.

Authors:  Richard B Parad; Janis L Breeze; Norma Terrin; Lynette K Rogers; Carolyn M Salafia; Anne Greenough; Jonathan M Davis
Journal:  Pediatr Pulmonol       Date:  2021-08-26

4.  Evaluation of Trends in Bronchopulmonary Dysplasia and Respiratory Support Practice for Very Low Birth Weight Infants: A Population-Based Cohort Study.

Authors:  Soon Min Lee; Lillian Sie; Jessica Liu; Jochen Profit; Henry C Lee
Journal:  J Pediatr       Date:  2021-11-25       Impact factor: 4.406

5.  Risk factors and bronchopulmonary dysplasia severity: data from the Spanish Bronchopulmonary Dysplasia Research Network.

Authors:  Cristina Ramos-Navarro; Elena Maderuelo-Rodríguez; Ana Concheiro-Guisán; Santiago Pérez-Tarazona; Santiago Rueda-Esteban; Ana Sánchez-Torres; Manuel Sánchez-Solís; Ester Sanz-López; Manuel Sánchez-Luna
Journal:  Eur J Pediatr       Date:  2021-10-01       Impact factor: 3.183

Review 6.  Bronchopulmonary Dysplasia: Then, Now, and Next.

Authors:  Michael C Tracy; David N Cornfield
Journal:  Pediatr Allergy Immunol Pulmonol       Date:  2020-09       Impact factor: 0.885

7.  Early angiogenic proteins associated with high risk for bronchopulmonary dysplasia and pulmonary hypertension in preterm infants.

Authors:  Sanne Arjaans; Brandie D Wagner; Peter M Mourani; Erica W Mandell; Brenda B Poindexter; Rolf M F Berger; Steven H Abman
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2020-01-22       Impact factor: 5.464

8.  Perinatal Hypoxia-Inducible Factor Stabilization Preserves Lung Alveolar and Vascular Growth in Experimental Bronchopulmonary Dysplasia.

Authors:  Kellen Hirsch; Elizabeth Taglauer; Gregory Seedorf; Carly Callahan; Erica Mandell; Carl W White; Stella Kourembanas; Steven H Abman
Journal:  Am J Respir Crit Care Med       Date:  2020-10-15       Impact factor: 21.405

Review 9.  Pulmonary Hypertension: The Hidden Danger for Newborns.

Authors:  Steven H Abman
Journal:  Neonatology       Date:  2021-05-05       Impact factor: 4.035

10.  Antenatal mesenchymal stromal cell extracellular vesicle treatment preserves lung development in a model of bronchopulmonary dysplasia due to chorioamnionitis.

Authors:  Alison N Abele; Elizabeth S Taglauer; Maricar Almeda; Noah Wilson; Abigail Abikoye; Gregory J Seedorf; S Alex Mitsialis; Stella Kourembanas; Steven H Abman
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2021-12-08       Impact factor: 5.464

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.